SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMNR - Immune Response

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John S. Baker who wrote (395)5/8/1998 10:19:00 AM
From: Robert DeHaven  Read Replies (2) of 1510
 
Manny & John et all: Look at the MACD stats this stock is under serious accumulation....this should not to be taken lightly or traded for short term dips....trading like this is usually indicative of a huge institutional order (200,000+) I believe there may be multiple orders like that given the strength of the bids, OBV, MACD and just plain ole gut feeling....we are headed much higher. The option premiums also are indicative of a higher stock price. The recent private placement was done at a premium $14+ while the stock was at 12...the total $10 mill was potentially $20 mill but the company again doesn't want existing shareholders to be screwed or think they were screwed....When the stock price reaches $20+ the shareholders naturally will look back and will be asking boy did those guys get a sweet deal.

This company is years ahead of companies highly touted recently like ENMD....The pro's know this and have begun to put up $$$....

We'll see.... once we break 14 3/4 most overhead resistance will be much lighter.

good luck,

bob
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext